ABCG26 (AT3G13220) is an Arabidopsis thaliana gene encoding a plasma membrane-localized ABC transporter essential for pollen exine formation and male fertility . Key features include:
Function: Transports sporopollenin precursors from tapetal cells to developing pollen grains .
Structure: Contains an N-terminal ATP-binding domain and a C-terminal transmembrane domain, typical of ABCG subfamily transporters .
Phenotype: Knockout mutants (e.g., abcg26-1) exhibit pollen wall defects and sterility .
While the provided sources do not explicitly describe a commercial ABCG26 antibody, studies employ alternative methods for protein characterization:
T-DNA insertion mutants: Used to study ABCG26 loss-of-function phenotypes (e.g., abcg26-1, abcg26-2) .
Complementation assays: Restored fertility in mutants via transgenic expression of ABCG26.1 or ABCG26.2 cDNA .
Subcellular localization: Achieved using YFP-ABCG26 fusion constructs transiently expressed in protoplasts .
For ABCG homologs like human ABCG2 (BCRP), antibodies such as ab130244 (Anti-BCRP/ABCG2 [1H2]) are widely used. Key applications include:
Application | Details |
---|---|
Western Blot | Detects ~72 kDa band in HepG2, COS7, and NIH/3T3 cell lysates . |
Immunofluorescence | Localizes ABCG2 in HeLa cells . |
ELISA | Validates binding to recombinant ABCG2 fragments . |
Role in sporopollenin transport: ABCG26 mediates the export of lipidic sporopollenin precursors from tapetal cells to the anther locule .
Localization: Plasma membrane-localized in tapetum cells during pollen development .
Mutant phenotype: abcg26-1 mutants show collapsed pollen grains with defective exine layers .
Feature | ABCG26 (Arabidopsis) | ABCG2 (Human) |
---|---|---|
Function | Pollen exine formation | Drug resistance, xenobiotic transport |
Localization | Tapetum plasma membrane | Brain endothelium, gastrointestinal tract |
Antibody Tools | No commercial antibody described | ab130244 (validated for WB, IF, ELISA) |
Structure | Predicted homodimer | Cryo-EM structure resolved (PDB: 5NIV) |
Antibody development: Generation of ABCG26-specific antibodies would enable direct protein quantification and tissue localization studies.
Biochemical profiling: Identify accumulated sporopollenin precursors in abcg26 mutants to elucidate transported substrates .
Structural studies: Apply cryo-EM techniques, as used for ABCG2 , to resolve ABCG26’s molecular architecture.
KEGG: ath:AT3G13220
STRING: 3702.AT3G13220.1
Here’s a structured FAQ collection for researchers investigating ABCG2 antibodies in academic contexts, synthesized from peer-reviewed methodologies and experimental insights:
Troubleshooting framework:
Integrated approach:
Critical steps:
Design sgRNAs targeting exon 2 (common to all splice variants).
Include ABCG2-GFP reporter lines to monitor transcriptional dynamics.
Validate off-target effects via RNA-seq in KO clones.
Antibody validation: Always pair antibody-based detection with functional readouts (e.g., drug IC50 shifts ≥5-fold post-Ko143 treatment ).
Data interpretation: Account for ABCG2 polymorphisms (e.g., C421A) that alter protein stability and substrate affinity .
Ethical reporting: Disclose antibody validation steps per Nature Publishing guidelines, including clone ID, dilution, and validation controls .